Medicare and most insurance do not cover GLP-1s for weight loss
Mounjaro is administered as a once-weekly subcutaneous injection, with doses including 2.5 mg, 5 mg, 7.5 mg, 10 mg, and 15 mg per 0.5 mL
Special population studies, including evaluation in elderly patients, patients with significant comorbidities, and patients with organ dysfunction, would help establish safety profiles for diverse clinical populations
You can also look at the Weight Loss Boost supplement for energy support during weight loss
Those controlled study amounts describe a different route and cannot be converted into subcutaneous syringe units or oral amounts
Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study